News
20h
Stories by SWNS on MSNBreakthrough offers hope for treating eczema and skin conditionsA new way of treating common inflammatory skin conditions such as eczema is on the horizon, according to a new study.
I am 72 years old and in good health. Last fall, I got weak and shaky while working in my yard. It was a hot day, so my son insisted on calling 911. They said it was heat exhaustion, and I got treated ...
A national trade body is urging the public to be vigilant to the dangers of an invasive weed that can cause injury in summer.
Protecting your child's skin is important, especially in the summer months when more skin is exposed.The dangers are ...
16h
HealthDay on MSNStudy Compares Benefits, Harms of Treatments for Chronic HivesHealthDay News — Omalizumab and remibrutinib may be the most effective treatments for reducing hives, itch, and swelling with chronic urticaria, according to a study published online July 15 in the ...
Sarah Neal first thought her rash might be linked to a new sunscreen. But when symptoms escalated quickly, two dermatologists ...
The U.S. Food and Drug Administration (FDA) has signed off on the first-ever cream specifically approved for treating chronic ...
Review compares patient-important outcomes and assesses evidence among 42 systemic treatments in patients in 93 studies.
The FDA approved Anzupgo for the treatment of moderate to severe chronic hand eczema in adults who do not adequately respond ...
Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for value-driven solutions.
Adult patients with moderate to severe hand eczema with previous treatment failure or in whom topical corticosteroids are ...
Danish dermatology specialist Leo Pharma has scored an FDA approval that makes its JAK inhibitor cream Anzupgo (del | Despite chronic hand eczema affecting 1 in 10 people worldwide, there was no ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results